Veronika Logonvinsky

VP Clinical Devlopment Lundbeck

Veronika Logovinsky has an MD and a PhD in Biophysics. She has received a B.S. degree in Applied Mathematics from Yale University, a M.A. degree in Chemical Physics from Columbia University and a combined MD/PhD degree from University of Pennsylvania. Her work in Biophysics utilized highly resolved fluorescence laser spectroscopy to study interactions of porphyrins with proteins in biologically important respiratory enzymes and to model behavior of proteins in complicated physiological systems. Following completion of the combined MD/PD program, Dr. Logovinsky completed residency in Psychiatry at Harvard University School of Medicine and is a board-certified psychiatrist with clinical experience in neuropsychiatric disorders. Dr. Logovinsky has worked in the pharmaceutical industry for over 20 years and has focused on the neuroscience therapeutic area. She has led programs across a broad spectrum of neurological and psychiatric indications, including neuroendocrinology disorders, pain, Alzheimer’s disease, and other neurodegenerative disorders. For the past six years she has worked at Lundbeck within a broad range of neurological and psychiatric disorders. Dr. Logovinsky has led Lundbeck’s neuropsychiatry group and has served as the clinical representative to Lundbeck’s business development function. During her extensive experience in pharmaceutical industry Dr. Logovinsky has worked with rare disorders. She continues to focus on rare neurological disorders at Lundbeck today.

Seminars

Wednesday 16th September 2026
Panel Discussion: Neuropsychiatry at a Crossroads: Where Science, Strategy & Deal Making Converge
9:45 am
  • What indications are you excited about and actively exploring?
  • Which drug modalities are you excited about and actively exploring?
  • In 2026 are we ready for precision psychiatry, and what might we need to improve in terms of diagnostics to get there (genetics, etc.)?
Veronika Logonvinsky